Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:22:10 EDT Mon 14 Jul 2025
Enter Symbol
or Name
USA
CA



C:DTC - Defence Therapeutics Inc. - Class A Common Shares - https://defencetherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DTC - C  3.50.66·0.725.00.66-0.02-2.956.739270.72  0.72  0.661.66  0.4814:23:1603:1615 min RT 2¢
CSE - C3.50.66·0.725.00.66-0.02-2.943.530210.72  0.72  0.661.66  0.4814:23:1615 min
Omega - O 0.66-0.02-2.96.0420.70  0.70  0.6614:23:1615 min
CX2 - H 0.66-0.02-2.97.0520.70  0.70  0.6614:23:1615 min
CXD - D 0.680.11    Jul 0915 min
TriAct - M 0.680.051    15 min

Recent Trades - Last 10 of 27
Time ETExPriceChangeVolumeBuyerSellerMarkers
14:23:16O0.66-0.023,5001 Anonymous1 AnonymousK
14:23:16H0.66-0.024,5001 Anonymous1 AnonymousK
14:23:16C0.66-0.022,00080 National Bank1 AnonymousK
12:34:31M0.66-0.02502 RBC1 AnonymousE
11:35:56C0.690.011,0001 Anonymous79 CIBCK
11:35:56C0.690.011,0001 Anonymous124 QuestradeK
09:34:58C0.690.014,00013 Instinet2 RBCK
09:34:46C0.700.0250033 Canaccord1 AnonymousK
09:34:46C0.700.021,50033 Canaccord1 AnonymousK
09:34:46C0.700.021,50033 Canaccord1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-07-14 16:19C:DTC0.66News ReleaseDefence continues Accum ADC, radiopharma programs
2025-06-09 10:20C:DTC0.82News ReleaseDefence receives USPTO allowance for patent application
2025-06-02 11:18C:DTC0.76News ReleaseDefence Therapeutics opens first U.S. laboratory
2025-05-28 03:16C:DTC0.87News ReleaseDefence Therapeutics to Attend Bio International Convention in Boston, June 2025
2025-05-23 16:17C:DTC0.85SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-05-23 16:17C:DTC0.85SEDAR Interim MD & ASEDAR Interim MD & A
2025-04-08 09:27C:DTC0.90News ReleaseDefence to study Accum in combination with actinium-225
2025-03-26 11:14C:DTC1.07News ReleaseDefence Therapeutics appoints Theodorou as COO
2025-02-25 18:12C:DTC0.99SEDAR Interim MD & ASEDAR Interim MD & A
2025-02-25 18:07C:DTC0.99SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-01-31 18:39C:DTC1.02News ReleaseDefence Therapeutics closes second tranche of financing
2025-01-10 17:23C:DTC0.65News ReleaseDefence closes $300,000 first tranche of placement
2025-01-06 10:38C:DTC0.65News ReleaseDefence talks patent allowances, applications
2024-12-31 17:28C:DTC0.66News ReleaseDefence Therapeutics arranges $4.2-million placement
2024-12-20 10:09C:DTC0.52News ReleaseDefence Therapeutics appoints Theodorou as director
2024-12-03 03:57C:DTC0.52News ReleaseDefence to hold AGM Dec. 12
2024-11-29 18:26C:DTC0.55News ReleaseDefence to license Accum to pharma, biotech companies
2024-11-25 09:57C:DTC0.52News ReleaseDefence appoints Parisotto as chief scientific officer
2024-11-22 19:10C:DTC0.52News ReleaseDefence Therapeutics closes $1.47M debenture offering
2024-11-14 19:44C:DTC0.60News ReleaseDefence to replace debentures with new debentures